Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris.

PUBLICATION: Transl Oncol. 2019 Sep 9;12(12):1557-1565. doi: 10.1016/j.tranon.2019.08.008. AUTHORS: Slembrouck Read More

2020-06-15T17:48:03-07:00September 9th, 2019|Evidence, MammaPrint, Slembrouck, Test Development, Translational Oncology|

MammaPrint and BluePrint Molecular Diagnostics Using Targeted RNA Next-Generation Sequencing Technology

PUBLICATION: Journal of Molecular Diagnostics September 2019 Volume 21, Issue Read More

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline

PUBLICATION: Journal of Clinical Oncology 37, no. 22 (August 01, Read More

Copy Number Profiling of MammaPrint Genes Reveals Association with the Prognosis of Breast Cancer Patients

PUBLICATION: J Breast Cancer. 2017 Sep;20(3):246-253. English. Published online Sep Read More

2020-06-15T18:02:53-07:00September 22nd, 2017|BluePrint, Evidence, Fatima, MammaPrint, Test Development|

Breast Cancer: Determining the Genetic Profile from Ultrasound-Guided Percutaneous Biopsy Specimens Obtained During Diagnostic Workups

PUBLICATION: Radiología (English Edition) Volume 58, Issue 3, May–June 2016, Read More

2020-06-15T18:47:33-07:00June 14th, 2016|Evidence, López Ruiz, MammaPrint, Radiología, Test Development|

Equivalence of MammaPrint Array Types in Clinical Trials and Diagnostics

PUBLICATION: Breast Cancer Res Treat (2016) 156: 279. https://doi.org/10.1007/s10549-016-3764-5 AUTHORS: Read More

MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue

PUBLICATION: J Mol Diagn. 2014 Mar;16(2):190-7. doi: 10.1016/j.jmoldx.2013.10.008. Epub 2013 Read More

MammaPrint Feasibility in a Large Tertiary Urban Medical Center: An Initial Experience

PUBLICATION: Scientifica (Cairo). 2012; 2012: 942507. Published online 2012 Dec 31. Read More

2012-12-31T18:56:42-08:00December 31st, 2012|Espinel, Evidence, MammaPrint, Scientifica, Test Development|

The EORTC 10041/BIG 03-04 MINDACT Trial is Feasible: Results of the Pilot Phase

PUBLICATION: European Journal of Cancer, December 2011, Volume 47, Issue 18, Read More

Go to Top